The broth microdilution procedure for quantitative antimicrobial susceptibility testing has become an acceptable alternative to the more cumbersome and often impractical agar and broth tube methods (1, 2, 5-9, 11, 12, 14-16) . The rapid emergence of commercial microdilution products has made the quantitative susceptibiity procedure readily available to most clinical microbiology laboratories. Some of these products (Micro-Media System, Sensititre, AST, and 3M-MPS) have been evaluated and found satisfactory for use in the clinical laboratory (2, 6, 8, 11, 12, 14, 15 ; E. H. Gerlach et al., manuscript in preparation). In addition, several semiautomated broth-dispensing devices (Dynatech MIC 2000, Sandy Springs Instruments Quick Spense II, and the Anderson Dispenser) which enable economical and rapid in-laboratory tray production may be purchased.
Two main differences in form have appeared among the commercially prepared microdilution products; a frozen tray with a relatively short shelf life and easy replicate inoculation and a second form that has dried antimicrobial agents in plastic trays needing broth rehydration combined with or followed by organism inoculation. Systems of the latter form have extended product shelf life to approximately 1 year stored at room temperature (6, 8) . Even with these procedural modifications of the microdilution method, the commercial products have been shown to produce test results, minimum inhibitory concentrations (MICs), comparable to those obtained with the World Health Organization International Collaborative Study broth method and the microdilution broth method utilizing trays manufactured in the clinical laboratory (2, 3, 6, 8, 11, 12, 14, 15) .
In this study we evaluate a new commercial microdilution product, the Sceptor system (BBL Microbiology Systems, Cockeysville, Md.) The Sceptor antimicrobial susceptibility test (SAST) system uses 84-well plastic trays containing dried antimicrobial agents at concentrations for determining the MICs of 12 drugs (log2 dilution scales, see Table 1 ). Unlike other dried antimicrobial products that use Mueller-Hinton broth (Difco Laboratories, Detroit, Mich.) with or without divalent cation supplement, the SAST system employs a special medium formulation said to contain cations and produce MICs similar to those in Mueller-Hinton broth. The trays and against broth microdilution trays (10) (2, 6) . Only those MICs -1 dilution removed from the extremes of the concentration range were considered to be "on-scale" endpoints, considering that the biological variabiity of the test method is ±1 log2 dilution interval. These strains were further selected to provide, where possible, four or more on-scale MICs for each antimicrobial agent, determined by testing four or more species. Three SAST tray types were used in phase 1. The RMD trays were produced to stimulate the antimicrobial agent concentrations and ranges found in the SAST.
An additional 176 bacteria were tested in phase 2. All tests were performed at the Center for Disease Control by using bacterial strains specifically selected to represent those organisms possessing antimicrobial resistance and susceptibility to all tested drugs (13 isolated colonies derived from a stock or fresh culture were picked from an overnight blood agar subculture; colonies were then inoculated into 0.5-ml brain heart infusion broth; the brain heart infusion broth was CMatched MIC pairs using both on-and off-scale endpoints.
ods. The intralaboratory reproducibility for the SAST varied from 97.0% at the Cleveland Clinic Foundation to 98.0% at the Kaiser Foundation Laboratory (97.6% overall). The RMD was 1.1% more reproducible; although a small difference, this was statistically significant (P < 0.05). The RMD showed a greater incidence of absolute agreement, 83.9 versus 77.8%, between intralaboratory trials.
The interlaboratory comparisons are summarized in Table 5 . These statistics were analyzed by comparing the MIC results of the individual laboratories to the modal MIC for that antibiotic and organism shown in Tables 2 and 3 . Variations were expressed in log2 dilution steps from that modal MIC, i.e., 0, 1, 2, and >-3. Again, the RMD showed a slightly higher reproducibility, which was statistically significant (P < 0.05).
The U.C. Davis Medical Center showed the best correlation with the mode for SAST and the highest variation for RMD. The opposite was true for the Kaiser Foundation Laboratory. As with the direct method MIC comparison, the strictly on-scale results gave similar findings, e.g., intralaboratory reproducibility (SAST, 97.7%; RMD, 98.5%) and interlaboratory reproducibility (SAST, 96.8%; RMD, 97.5%).
Phase 2 of the study used 176 stock bacteria from the collection of C. Thornsberry . Each organism was tested on two tray types, e.g., Enterobacteriaceae and nonfermentative gramnegative bacteria were tested in gram-negative and urine trays and the streptococci and staphylococci were inoculated into gram-positive and urine trays. Results were logged as SAST MIC/ RMD MIC ratios (Table 6 ). Minimal variation between method results was found. The best comparison was with the streptococci (99.0% with ratios of 0.5, 1, or 2), though a general tendency toward slightly lower SAST MICs was noted. The lower correlation among the staphylococci was principally due to discrepant penicillin MICs between the susceptibility testing methods.
The examination of individual antimicrobial MICs by organism group showed some skewing (slog2 dilution step) of results between methods. The Enterobacteriaceae had higher SAST MICs for tobramycin and lower MICs for carbenicillin, cephalothin, nitrofurantoin, and tetracycline when compared with the RMD results. For the nonenteric, gram-negative bacilli, the SAST tobramycin MICs were again higher, and those of carbenicillin, tetracycline, and trimethoprim/sulfamethoxazole were lower. The staphylococci showed an MIC correlation of 79.3% for methicillin due to generally lower RMD results. Amikacin, tobramycin, and nitrofurantoin also had staphylococcal SAST MIC/RMD MIC ratios of 0.5. Ratios of 2 were most often seen with chloramphenicol and tetracycline. The streptococci were mostly serogroup D species, and these strains demonstrated excellent correlation between MIC methods in this study section. However, minor MIC shifts were identified for these streptococci with clindamycin and erythromycin with ratios near 2 and all aminoglycosides, carbenicillin, and tetracycline with ratios near 0.5. This aminoglycoside MIC shift was similar to that reported for other dried antimicrobial products ( paradoxically lower SAST aminoglycoside MICs (on stock strains) were seen for enterococci of clinical origin. Of the 129 clinical on-scale MIC test pairs differing by >±1 log2 dilution step (ratios '0.25 or -4), only 16 would have resulted in significant susceptibility category changes. Six (0.2%) very major errors, i.e., a sensitive SAST MIC and a resistant RMD MIC, were identified. The organism-antimicrobial agent combinations included: S. faecalis-gentamicin, 4; S. epidermidis-tetracycline, 1; and Aeromonas hydrophilatrimethoprim/sulfamethoxazole, 1. Major errors (SAST false-resistance) were 0.3%, with the majority being obtained with the combination of cefamandole tested against a beta-lactamaseproducing Citrobacter, Enterobacter, or Morganella. In this latter case the SAST result may be more accurate because of the susceptibility of this cephalosporin to these beta-lactamases. 
DISCUSSION
Early evaluations of the microdilution broth antimicrobial susceptibility method have resulted in favorable reports of MIC comparability, accuracy, and reproducibility (2, 5, 6, 9, 16) . As more clinical microbiology laboratories have adopted this methodology, numerous commercial products have become available for in-laboratory tray manufacture or as previously prepared reagents. The latter products have generally offered a greater degree of standardization of the methodology and reagents than that possible by in-laboratory tray production. Fortunately, these products have appeared simultaneously with an increasing sophistication in in-fectious disease therapy and escalated antimicrobial research and development. This greater demand for quantitative antimicrobial results has brought previously prepared microdilution broth trays into hundreds of laboratories unable or unwilling to produce their own susceptibility testing trays.
We have previously evaluated commercially prepared susceptibility trays as to comparative (14, 15) .
In this study, SAST trays from 11 lots were tested for comparative accuracy and reproducibility in three study sections. The accuracy of the SAST MIC was compared directly with single lots of microdilution broth panels produced by the investigators (10 
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The SAST intralaboratory and interlaboratory reproducibiity in all study sections was excellent and comparable to that of the RMD method (10) . The intralaboratory variation outside of the acceptable ± 1 dilution range was only 2.4% for the stock isolates (triplicate testing) and 3.2% for the recent clinical strains (two trials). The SAST interlaboratory variation was measured only against the 26 stock strains. A total of 159 (2.8%) comparisons were beyond the acceptable limits, principally due to poor reproducibility of aminoglycoside MICs (related to ail laboratory modes) against serogroup D streptococci tested at the Kaiser Foundation Laboratory. Again, these excellent results were only equalled in our experience by the comparative RMD reproducibility performed on a single lot of trays in contrast to multiple lots for the SAST. In studies of other dried antimicrobial products, the frequency of "skip patterns" was higher than that of the RMD (8; Gerlach et al., in preparation). However, in our study rare skips were observed in both test systems. Great care in the micropipetting of the SAST inoculum into the trays certainly contributed to this low skip pattern frequency related to the replicate inoculated reference procedure. The time needed to pipette the SAST inoculum into the trays was judged by the participating technical staff at two-to threefold longer than the replicate inoculation of the RMD. Such a cumbersome and tedious procedural step limits the utility of the dried antimicrobial products, though they have the significant advantage of a long shelf life (-12 months). A semiautomated rapid inoculum preparation and tray rehydration device, currently in laboratory trials, would offer significant time savings and acceptance by laboratories processing higher volumes.
In addition to the favorable comparison and reproducibility statistics, the SAST readily categorizes the resistant and sensitive strains within various bacterial genera and species. This was especially evident for the methicillin-resistant staphylococci, beta-lactamase-producing Enterobacteriaceae, aminoglycoside-inactivating (enzymes) pseudomonads, and enteric bacteria. Only rare (0.2%) very 
